XML 44 R25.htm IDEA: XBRL DOCUMENT
v3.19.1

Segment Information | 3 Months Ended
--- | ---
Mar. 31, 2019
Segment Reporting [Abstract] |
Segment Information | Segment Information Our business operations are organized into two reportable segments, Proprietary Products and Contract-Manufactured Products. Our Proprietary Products reportable segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. Our Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. We evaluate the performance of our segments based upon, among other things, segment net sales and operating profit. Segment operating profit excludes general corporate costs, which include executive and director compensation, stock-based compensation, adjustments to annual incentive plan expense for over- or under-attainment of targets, certain pension and other retirement benefit costs, and other corporate facilities and administrative expenses not allocated to the segments. Also excluded are items that we consider not representative of ongoing operations. Such items are referred to as other unallocated items and generally include restructuring and related charges, certain asset impairments and other specifically-identified income or expense items. The following table presents information about our reportable segments, reconciled to consolidated totals:
| Three Months Ended March 31,
($ in millions) | 2019 |  | 2018
Net sales: |  |  |
Proprietary Products | $ | 340.4 |  |  | $ | 326.2 |
Contract-Manufactured Products | 103.1 |  |  | 89.5 |
Consolidated net sales | $ | 443.5 |  |  | $ | 415.7 |
Operating profit (loss): |  |  |
Proprietary Products | $ | 77.0 |  |  | $ | 62.8 |
Contract-Manufactured Products | 10.5 |  |  | 9.5 |
Corporate | (16.2 | ) |  | (15.6 | )
Other unallocated items | (0.6 | ) |  | (3.3 | )
Total operating profit | $ | 70.7 |  |  | $ | 53.4 |
Interest expense | 2.3 |  |  | 1.9 |
Interest income | (0.9 | ) |  | (0.6 | )
Other nonoperating income | (0.6 | ) |  | (1.6 | )
Income before income taxes | $ | 69.9 |  |  | $ | 53.7 |
Other unallocated items during the three months ended March 31, 2019 and 2018, consisted of $0.6 million and $3.3 million, respectively, in restructuring and related charges. Please refer to Note 15, Other (Income) Expense, for further discussion of these items.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration